Sublingual sildenafil dissolves under the tongue for faster absorption — working in as little as 15 minutes compared to 30–60 minutes for standard oral tablets. Prescribed by board-certified physicians after a live consultation. Custom compounded doses available.
When you swallow a sildenafil tablet, it passes through your stomach and liver before reaching systemic circulation (first-pass metabolism). This takes 30–60 minutes and reduces how much active drug reaches its target. Sublingual troches dissolve under your tongue and absorb directly into the blood vessels of the oral mucosa, bypassing the stomach and liver. The result: faster onset (typically 15–20 minutes), potentially higher bioavailability, and efficacy that isn't blunted by a recent meal — food significantly delays oral tablet absorption.
Sildenafil blocks phosphodiesterase type 5 (PDE5), which normally breaks down cyclic GMP (cGMP) — the signaling molecule that relaxes smooth muscle and dilates blood vessels in the penile corpus cavernosum. By blocking PDE5, sildenafil allows cGMP to accumulate in response to sexual stimulation, producing and sustaining erection. Sexual arousal is still required; sildenafil enhances the body's natural response rather than creating one artificially.
Take 15–30 minutes before anticipated activity. Do not exceed one dose per 24 hours.
Common, typically mild: headache, facial flushing, nasal congestion, indigestion, visual color changes (rare blue tint).
Seek emergency care for erection lasting more than 4 hours (priapism), sudden vision loss, sudden hearing loss, or chest pain.
Do NOT take sildenafil if you: take nitrate medications (nitroglycerin, isosorbide) for chest pain — the combination can cause life-threatening hypotension; take riociguat; have had a recent heart attack or stroke; have severe cardiovascular disease. Caution with alpha-blockers.
Medical disclaimer: Educational content, not medical advice. Page medically reviewed by Teja V. Surapaneni, MD, MS — Board-Certified Internal Medicine (NV, WA, OR, WY). Last reviewed: April 17, 2026